Skip to content
PICO Portalanswers from OpenAlex

Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation

PaperCitations, authors & open-access status

Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation is a paper indexed in PICO Portal from OpenAlex.

How many citations does Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation have?

PICO Portalcitation count

Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation has 2 citations in the OpenAlex counts PICO Portal stores.

When was Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation published?

PICO Portalyear

Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation has 2025 year in the PICO Portal index.

What is the open-access status of Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation?

PICO Portaloa status

Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation has closed oa status in the PICO Portal index.

What is the DOI of Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation?

PICO Portaldoi

The DOI for Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation is on the source record.

What is the PMID of Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation?

PICO Portalpmid

The PMID for Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation is on the source record.

What is the OpenAlex record for Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation?

PICO Portalopenalex

The OpenAlex for Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial